Protagonist Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PTGX research report →
About the company
Protagonist Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering and advancing peptide-based therapies. Their research primarily focuses on treatments for hematological and blood conditions, as well as inflammatory and immune-mediated disorders.
- CEO
- Dinesh V. Patel
- IPO
- 2016
- Employees
- 124
- HQ
- Newark, CA, US
Price Chart
- Market Cap
- $8.46B
- P/E
- -73.05
- P/S
- 114.29
- P/B
- 13.07
- EV/EBITDA
- -72.68
- Div Yield
- 0.00%
- Gross Margin
- 99.45%
- Op Margin
- -192.36%
- Net Margin
- -154.88%
- ROE
- -17.76%
- ROIC
- -21.29%
- Revenue
- $46.02M · -89.41%
- Net Income
- $-130,149,000 · -147.29%
- EPS
- $-2.05 · -145.86%
- Op Income
- $-158,127,000
- FCF YoY
- -69.32%
- 52W High
- $131.87
- 52W Low
- $49.38
- 50D MA
- $105.70
- 200D MA
- $90.37
- Beta
- 1.79
- Avg Volume
- 692.91K
Get TickerSpark's AI analysis on PTGX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 23, 26 | Waddill William D. | other | 9,000 |
| Jun 23, 26 | Waddill William D. | sell | 9,000 |
| Jun 23, 26 | Waddill William D. | other | 9,000 |
| Jun 10, 26 | Waddill William D. | other | 6,000 |
| Jun 10, 26 | Waddill William D. | other | 3,000 |
| Jun 10, 26 | Waddill William D. | other | 6,000 |
| Jun 10, 26 | Waddill William D. | sell | 9,000 |
| Jun 10, 26 | Waddill William D. | other | 3,000 |
| May 29, 26 | Waddill William D. | other | 9,000 |
| May 29, 26 | Waddill William D. | sell | 9,000 |
Our PTGX coverage
Recent articles, reports, and earnings notes.
Want a deeper read on PTGX?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Similar companies
Peers in the same neighborhood.